🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

PRECIOUS-Gold dips to four-month low as vaccine hopes take centre stage

Published 24/11/2020, 11:28
© Reuters.
XAU/USD
-
XAG/USD
-
AZN
-
GC
-
SI
-
MRNA
-

(Updates prices, adds context)
* Gold's break below $1,800/oz could prompt further dip
-analyst
* European shares gain on vaccine optimism
* EU reaches deal with Moderna for vaccine supply
* Interactive graphic tracking global spread of coronavirus:
* https://tmsnrt.rs/3aIRuz7 in an external browser

By Asha Sistla
Nov 24 (Reuters) - Gold slid to a four-month low on Tuesday,
extending a sharp slide from the previous session as optimism
over the development of COVID-19 vaccines drove investors to
riskier assets.
Spot gold XAU= dropped 1.3% to $1,812.81 an ounce by 1218
GMT, having touched its lowest since July 17 at $1,804.70, while
U.S. gold futures GCv1 lost 1.5% to $1,810.60.
European equities rose on a possible easing of COVID-19
curbs and progress on vaccines from the likes of AstraZeneca
AZN.L , Pfizer PFE.N and Moderna MRNA.O . .EU European Union has reached a deal with U.S. biotech
company Moderna for supply of its vaccine, an EU official told
Reuters on Tuesday. "We had news about the vaccine, saw yields moving higher in
U.S.; even the dollar went lower and gold is not profiting from
that ... This is a very bad sign for gold and means there is
underlying weakness building up," said ABN Amro analyst
Georgette Boele.
A break below support at $1,800 would trigger further price
declines, Boele added.
The dollar held close to its lowest in nearly three months,
potentially making gold cheaper for buyers with other
currencies. USD/ US/
Equities markets were also supported by clearance for U.S.
President-elect Joe Biden's transition to the White House, even
though President Donald Trump stopped short of conceding defeat
in the Nov. 3 election.
"The acknowledgement of Biden's victory from the Republicans
is likely to reduce the risk of further tensions and represents
a supportive element for stocks, while haven assets such as gold
are suffering," ActivTrades' chief analyst Carlo Alberto De Casa
said in a note.
However, central banks will still be forced to print a huge
amount of money, which could revive investor interest in gold
before long, De Casa added.
Gold is considered a hedge against inflation and currency
debasement that is likely to result from unprecedented global
stimulus to fight the economic impact of the COVID-19 pandemic.

In other precious metals, silver XAG= dipped 1.4% to
$23.25 an ounce, platinum XPT= was flat at $925.87 and
palladium XPD= dropped 1.4% to $2,323.13.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.